These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37510859)

  • 1. The Role of Donor Gamma-Glutamyl Transferase as a Risk Factor for Early Graft Function after Liver Transplantation.
    Lai Q; Melandro F; Manzia TM; Spoletini G; Crovetto A; Gallo G; Hassan R; Mennini G; Angelico R; Avolio AW; Berrevoet F; Abreu de Carvalho L; Agnes S; Tisone G; Rossi M
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of serum aspartate transaminase and gamma-glutamyl transferase in liver deceased donors.
    Capelli R; Kitano Y; Linhares M; Da Silva D; Golse N; Karam V; Sa Cunha A; Vibert E; Azoulay D; Cherqui D; Adam R; Allard MA
    Transpl Int; 2021 Nov; 34(11):2247-2256. PubMed ID: 34288136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor Gamma-Glutamyl Transferase Is Associated With Liver Allograft Discard and Failure.
    Zhang T; Hickner B; Cotton R; Nguyen Galvan NT; Vierling JM; O'Mahony C; Goss JA; Rana A
    Prog Transplant; 2021 Jun; 31(2):101-107. PubMed ID: 33729047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
    Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
    Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of donor liver graft quality on postoperative outcome in liver transplant recipients. A single centre experience.
    Tomescu D; Popescu M; Jipa L; Fota R; Ungureanu D; Zamfir R; Orban C; Dima SO; Popescu I
    Rom J Anaesth Intensive Care; 2016 Apr; 23(1):19-26. PubMed ID: 28913473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamyltransferase predicts macrovesicular liver graft steatosis - an analysis of discarded liver allografts in Finland.
    Savikko J; Åberg F; Tukiainen E; Nordin A; Mäkisalo H; Arola J; Isoniemi H
    Scand J Gastroenterol; 2023 Apr; 58(4):412-416. PubMed ID: 36308000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who is too healthy and who is too sick for liver transplantation: external validation of prognostic scores and survival-benefit estimation.
    Åberg F; Nordin A; Mäkisalo H; Isoniemi H
    Scand J Gastroenterol; 2015; 50(9):1144-51. PubMed ID: 25865580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers.
    Benko T; Gallinat A; Minor T; Saner FH; Sotiropoulos GC; Paul A; Hoyer DP
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):716-722. PubMed ID: 28441690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Donor Risk Index, Recipients' and Operative Characteristics on Post Liver Transplant One-Year Graft Failure: A Cohort Analysis.
    Cardoso FS; Bagulho L; Coelho JS; Lamelas J; Mateus É; Mendes M; Glória H; Ribeiro V; Mega R; Pena A; Marques HP; Germano N; Nolasco F; Perdigoto R; Martins A
    GE Port J Gastroenterol; 2023 Aug; 30(4):275-282. PubMed ID: 37767309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.
    Salvalaggio PR; Dzebisashvili N; MacLeod KE; Lentine KL; Gheorghian A; Schnitzler MA; Hohmann S; Segev DL; Gentry SE; Axelrod DA
    Liver Transpl; 2011 Mar; 17(3):233-42. PubMed ID: 21384505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity.
    Schrem H; Reichert B; Frühauf N; Becker T; Lehner F; Kleine M; Bektas H; Zachau L; Klempnauer J
    Ann Transplant; 2012; 17(3):5-13. PubMed ID: 23018250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment in High- and Low-MELD Liver Transplantation.
    Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
    Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation.
    Yang M; Khan AR; Lu D; Wei X; Shu W; Xu C; Pan B; Zhou Z; Wang R; Wei Q; Cen B; Cai J; Zheng S; Xu X
    Front Med (Lausanne); 2022; 9():772048. PubMed ID: 35308496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the comprehensive complication index for the prediction of survival after liver transplantation.
    Lai Q; Melandro F; Nowak G; Nicolini D; Iesari S; Fasolo E; Mennini G; Romano A; Mocchegiani F; Ackenine K; Polacco M; Marinelli L; Ciccarelli O; Zanus G; Vivarelli M; Cillo U; Rossi M; Ericzon BG; Lerut J
    Updates Surg; 2021 Feb; 73(1):209-221. PubMed ID: 32892294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.